Robert Allen
Chief Tech/Sci/R&D Officer at INVIVYD, INC.
Net worth: - $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Marc Elia | M | 48 | 2 years | |
| Terry McGuire | M | 68 | 4 years | |
| William Duke | M | 51 | 1 years | |
| Sara Cotter | F | 43 | 1 years | |
| Christine Regan Lindenboom | F | 43 | 2 years | |
| Jill Andersen | F | 51 | 3 years | |
| Jeremy Gowler | M | 47 | 2 years | |
| Stacy Price | F | 55 | 1 years | |
| Tamsin Berry | F | 43 | 2 years | |
| Julie Green | F | 49 | - | |
| Heidi Spurling | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Hering | M | 49 | 3 years | |
| Fred Driscoll | M | 73 | 1 years | |
| Michael Wyzga | M | 69 | 3 years | |
| John Thomas | M | 70 |
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | 3 years |
| Tomas Jan Heyman | M | 68 | 3 years | |
| Peter Schmidt | M | - | - | |
| Clive Meanwell | M | 67 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 18 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert Allen
- Personal Network
